Artiva Biotherapeutics, Inc.

Historical 13F Holders

Symbol
ARTV
CUSIP
04317A107
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 04317A107 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13D/A
37.9% 7/23/2026
Event 7/22/2026
GC Corp. 13D/A
12.3% 5/28/2026
Event 5/11/2026
Viking Global Investors LP 13G
5.4% 5/18/2026
Event 5/11/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
venBio Global Strategic Fund III, L.P. 13G/A
4.9% 5/15/2025
Event 3/31/2025
5AM Ventures VI, L.P. 13G/A
4.8% 8/10/2026
Event 6/30/2026
Venrock Healthcare Capital Partners III, L.P. 13G/A
4.2% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G/A 2.0% 7/16/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 99 41.2 M $287M
2026 Q2 72 40.4 M $392M
2026 Q1 40 16.8 M $108M
2025 Q4 34 17.0 M $72.7M
2025 Q3 40 18.2 M $52.1M
2025 Q2 49 18.5 M $27.9M
2025 Q1 54 20.9 M $62.8M
2024 Q4 58 21.2 M $213M
2024 Q3 50 20.7 M $319M